Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Is Franklin LibertyQ U.S. Equity ETF (FLQL) A Strong ETF Right Now?

Published 12/12/2018, 09:27 PM
Updated 07/09/2023, 06:31 AM

The Franklin LibertyQ U.S. Equity ETF (FLQL) made its debut on 04/26/2017, and is a smart beta exchange traded fund that provides broad exposure to the Style Box - Large Cap Blend category of the market.

What Are Smart Beta ETFs?

Products that are based on market cap weighted indexes, which are strategies designed to reflect a specific market segment or the market as a whole, have traditionally dominated the ETF industry.

Because market cap weighted indexes provide a low-cost, convenient, and transparent way of replicating market returns, they work well for investors who believe in market efficiency.

If you're the kind of investor who would rather try and beat the market through good stock selection, then smart beta funds are your best choice; this fund class is known for tracking non-cap weighted strategies.

By attempting to pick stocks that have a better chance of risk-return performance, non-cap weighted indexes are based on certain fundamental characteristics, or a combination of such.

Methodologies like equal-weighting, one of the simplest options out there, fundamental weighting, and volatility/momentum based weighting are all choices offered to investors in this space, but not all of them can deliver superior returns.

Fund Sponsor & Index

Managed by Franklin Templeton Investments, FLQL has amassed assets over $396.50 M, making it one of the average sized ETFs in the Style Box - Large Cap Blend. This particular fund, before fees and expenses, seeks to match the performance of the LibertyQ US Large Cap Equity Index.

The U.S. Large Cap Underlying Index seeks to achieve a lower level of risk and higher risk-adjusted performance than the Russell 1000 Index over the long term by applying a multi-factor selection process, which is designed to select equity securities from the Russell 1000 Index that have favorable exposure to four investment style factors quality, value, momentum and low volatility.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Cost & Other Expenses

When considering an ETF's total return, expense ratios are an important factor. And, cheaper funds can significantly outperform their more expensive cousins in the long term if all other factors remain equal.

Annual operating expenses for FLQL are 0.25%, which makes it on par with most peer products in the space.

It has a 12-month trailing dividend yield of 1.64%.

Sector Exposure and Top Holdings

While ETFs offer diversified exposure, which minimizes single stock risk, a deep look into a fund's holdings is a valuable exercise. And, most ETFs are very transparent products that disclose their holdings on a daily basis.

FLQL's heaviest allocation is in the Information Technology sector, which is about 19.70% of the portfolio. Its Consumer Discretionary and Consumer Staples round out the top three.

Looking at individual holdings, Eli Lilly + Co (LLY) accounts for about 1.34% of total assets, followed by Procter + Gamble Co/the (PG) and Pfizer Inc (PFE).

The top 10 holdings account for about 12.04% of total assets under management.

Performance and Risk

The ETF return is roughly 2.61% and was up about 3.76% so far this year and in the past one year (as of 12/13/2018), respectively. FLQL has traded between $27.88 and $31.54 during this last 52-week period.

FLQL has a beta of 0.80 and standard deviation of 10.74% for the trailing three-year period. With about 249 holdings, it effectively diversifies company-specific risk.

Alternatives

Franklin LibertyQ U.S. Equity ETF is a reasonable option for investors seeking to outperform the Style Box - Large Cap Blend segment of the market. However, there are other ETFs in the space which investors could consider.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

IShares Core S&P 500 ETF (IVV) tracks S&P 500 Index and the SPDR S&P 500 ETF (NYSE:SPY) tracks S&P 500 Index. IShares Core S&P 500 ETF has $154.80 B in assets, SPDR S&P 500 ETF has $250.66 B. IVV has an expense ratio of 0.04% and SPY charges 0.09%.

Investors looking for cheaper and lower-risk options should consider traditional market cap weighted ETFs that aim to match the returns of the Style Box - Large Cap Blend.

Bottom Line

To learn more about this product and other ETFs, screen for products that match your investment objectives and read articles on latest developments in the ETF investing universe, please visit Zacks ETF Center.



FL-LBTY US EQ (FLQL): ETF Research Reports

Pfizer Inc. (NYSE:PFE

Eli Lilly and Company (NYSE:LLY

ISHARS-SP500 (IVV): ETF Research Reports

SPDR-SP 500 TR (SPY): ETF Research Reports

Procter & Gamble Company (The) (NYSE:PG

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.